i-SENS, Inc. (KOSDAQ: 099190)

Market Cap	457.62B
Revenue (ttm)	280.29B
Net Income (ttm)	-3.53B
Shares Out	27.63M
EPS (ttm)	-128.17
PE Ratio	n/a
Forward PE	59.62
Dividend	100.00 (0.58%)
Ex-Dividend Date	n/a

Volume	274,804
Open	17,430
Previous Close	17,340
Day's Range	17,100 - 18,150
52-Week Range	14,520 - 39,700
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About i-SENS

i-SENS, Inc. engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally. The company offers blood glucose monitoring devices; diabetes care, acute care, and coagulation care devices; veterinary care devices; and accessory products. It also provides SmartLog, a diabetes management software for mobile and PC. The company was founded in 2000 and is headquartered in Seoul, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 827
• Stock Exchange: KOSDAQ
• Ticker Symbol: 099190

Financial Performance

In 2023, i-SENS's revenue was 265.12 billion, an increase of 0.11% compared to the previous year's 264.84 billion. Earnings were 3.71 billion, a decrease of -77.02%.